Retour
46
62
Fourchette du Jour
348,61 €
353,42 €
Fourchette 52 Semaines
261,43 €
391,29 €
Volume
2 218 975
Moyenne 50J / 200J
359,42 €
/
316,58 €
Clôture Précédente
347,80 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 24,5 | 0,4 |
| P/B | 21,8 | 2,9 |
| ROE % | 106,1 | 3,7 |
| Net Margin % | 21,0 | 3,8 |
| Rev Growth 5Y % | 9,1 | 10,0 |
| D/E | 6,3 | 0,2 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 |
Graham Jonathan P
EVP & Gen. Counsel & Sec.
|
other | 5 353 | 366,21 € | 1 960 322 € |
| Mar 16, 2026 |
Miller Derek
SVP, Human Resources
|
other | 1 616 | 366,21 € | 591 795 € |
| Mar 16, 2026 |
Gordon Murdo
EVP, Global Commercial Ops
|
other | 6 691 | 366,21 € | 2 450 311 € |
| Mar 16, 2026 |
Santos Esteban
EVP, Operations
|
other | 5 621 | 366,21 € | 2 058 466 € |
| Mar 3, 2026 |
Khosla Rachna
SVP, Business Development
|
grant | 1 876 | — | — |
| Mar 3, 2026 |
Miller Derek
SVP, Human Resources
|
grant | 3 484 | — | — |
| Mar 3, 2026 |
Grygiel Nancy A.
SVP & CCO
|
grant | 2 010 | — | — |
| Mar 3, 2026 |
REESE DAVID M
EVP & Chief Technology Officer
|
grant | 12 063 | — | — |
| Feb 19, 2026 |
Busch Matthew C.
VP, Finance & CAO
|
sell | 1 000 | 375,79 € | 375 790 € |
| Nov 12, 2025 |
Khosla Rachna
SVP, Business Development
|
sell | 890 | 336,24 € | 299 256 € |
| Aug 8, 2025 |
ISHRAK OMAR
Director
|
grant | 121 | — | — |
| Aug 8, 2025 |
HOLLEY CHARLES M
Director
|
grant | 147 | — | — |
| May 23, 2025 |
Garland Greg C.
Director
|
grant | 809 | — | — |
| May 23, 2025 |
Austin Wanda M
Director
|
grant | 809 | — | — |
| May 23, 2025 |
ECKERT ROBERT
Director
|
grant | 809 | — | — |
| May 23, 2025 |
Jacks Tyler
Director
|
grant | 809 | — | — |
| May 6, 2025 |
Busch Matthew C.
VP, Finance & CAO
|
grant | 4 139 | — | — |
| May 6, 2025 |
ISHRAK OMAR
Director
|
grant | 129 | — | — |
| May 2, 2025 |
Grygiel Nancy A.
SVP & CCO
|
other | 229 | 283,78 € | 64 986 € |
| May 2, 2025 |
Miller Derek
SVP, Human Resources
|
other | 349 | 283,78 € | 99 039 € |
Points Clés
Revenue grew 9,05% annually over 5 years — modest growth
Earnings grew 88,53% over the past year
ROE of 106,10% indicates high profitability
Net margin of 20,99% shows strong profitability
Debt/Equity of 6,31 — high leverage
Generating 8,10B in free cash flow
Croissance
Revenue Growth (5Y)
9,05%
Revenue (1Y)9,92%
Earnings (1Y)88,53%
FCF Growth (3Y)4,91%
Qualité
Return on Equity
106,10%
ROIC12,66%
Net Margin20,99%
Op. Margin29,06%
Sécurité
Debt / Equity
6,31
Current Ratio1,14
Interest Coverage3,88
Valorisation
P/E Ratio
24,45
P/B Ratio21,78
EV/EBITDA21,92
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,92% | Revenue Growth (3Y) | 14,16% |
| Earnings Growth (1Y) | 88,53% | Earnings Growth (3Y) | 7,14% |
| Revenue Growth (5Y) | 9,05% | Earnings Growth (5Y) | 6,95% |
| Profitability | |||
| Revenue (TTM) | 36,74B | Net Income (TTM) | 7,71B |
| ROE | 106,10% | ROA | 8,51% |
| Gross Margin | 70,80% | Operating Margin | 29,06% |
| Net Margin | 20,99% | Free Cash Flow (TTM) | 8,10B |
| ROIC | 12,66% | FCF Growth (3Y) | 4,91% |
| Safety | |||
| Debt / Equity | 6,31 | Current Ratio | 1,14 |
| Interest Coverage | 3,88 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 24,45 | P/B Ratio | 21,78 |
| P/S Ratio | 5,13 | PEG Ratio | 0,26 |
| EV/EBITDA | 21,92 | Dividend Yield | 0,03% |
| Market Cap | 188,55B | Enterprise Value | 234,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 36,74B | 33,42B | 28,19B | 26,32B | 25,98B |
| Net Income | 7,71B | 4,09B | 6,72B | 6,55B | 5,89B |
| EPS (Diluted) | 14,23 | 7,56 | 12,49 | 12,11 | 10,28 |
| Gross Profit | 26,01B | 20,57B | 19,78B | 19,92B | 19,53B |
| Operating Income | 10,68B | 7,26B | 7,90B | 9,57B | 7,64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90,59B | 91,84B | 97,15B | 65,12B | 61,17B |
| Total Liabilities | 81,93B | 85,96B | 90,92B | 61,46B | 54,47B |
| Shareholders' Equity | 8,66B | 5,88B | 6,23B | 3,66B | 6,70B |
| Total Debt | 54,60B | 60,10B | 64,61B | 38,95B | 33,31B |
| Cash & Equivalents | 9,13B | 11,97B | 10,94B | 7,63B | 7,99B |
| Current Assets | 29,06B | 29,03B | 30,33B | 22,19B | 19,39B |
| Current Liabilities | 25,49B | 23,10B | 18,39B | 15,69B | 12,18B |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#84 of 213
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#87 of 326
Activité Récente
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026